Risk of endometrial cancer mortality by ever-use of sex hormones and other factors in Japan

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 2, 2006, Pages 260-266

  Khan, M M H ^a,c   Mori, Mitsuru ^a,c   Sakauchi, Fumio ^a,c   Aklimunnessa, Khandoker ^a,c   Kubo, Tatsuhiko ^b,c   Fujino, Yoshihisa ^b,c   Suzuki, Sadao ^c,d   Tokudome, Shinkan ^c,d   Tamakoshi, Akiko ^c,e   Motohashi, Yutaka ^f   Tsuji, Ichiro ^g   Nakamura, Yosikazu ^h   Iso, Hiroyasu ⁱ   Mikami, Haruo ^j   Inaba, Yutaka ^k   Hoshiyama, Yoshiharu ^l   Suzuki, Hiroshi ^m   Shimizu, Hiroyuki ⁿ   Toyoshima, Hideaki ^e   Wakai, Kenji ^o   Ito, Yoshinori ^p   Hashimoto, Shuji ^q   Kikuchi, Shogo ^r   Koizumi, Akio ^s   Kawamura, Takashi ^s   Watanabe, Yoshiyuki ^t   Miki, Tsuneharu ^t   Date, Chigusa ^u   Sakata, Kiyomi ^v   Nose, Takayuki ^w   Hayakawa, Norihiko ^x   Yoshimura, Takesumi ^y   Shibata, Akira ^z   Okamoto, Naoyuki ^aa   Shio, Hideo ^ab   Ohno, Yoshiyuki ^ac   Kitagawa, Tomoyuki ^ad   Kuroki, Toshio ^ae   Tajima, Kazuo ^o   Shimamoto, Takashi ⁱ   Tanaka, Heizo ^af   Hisamichi, Shigeru ^g   Nakao, Masahiro ^ag   Suzuki, Takaichiro ^ah   Hashimoto, Tsutomu ^v   Ishibashi, Teruo ^ai   Fukuda, Katsuhiro ^z   more..

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c Fukuoka Institute of Occupational Health   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h JICHI MEDICAL UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j CHIBA CANCER CENTER   (Japan)

^k JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l UNIVERSITY OF HUMAN ARTS AND SCIENCES   (Japan)

^m NIIGATA UNIVERSITY   (Japan)

ⁿ GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o AICHI CANCER CENTER HOSPITAL   (Japan)

^p FUJITA HEALTH UNIVERSITY   (Japan)

^q FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s KYOTO UNIVERSITY   (Japan)

^t KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^u MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^v WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^w TOTTORI UNIVERSITY   (Japan)

^x HIROSHIMA UNIVERSITY   (Japan)

^y FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^z KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aa KANAGAWA CANCER CENTER   (Japan)

^ab Moriyama Municipal Hospital   (Japan)

^ac Asahi Rosai Hospital   (Japan)

^ad CANCER CHEMOTHERAPY CENTER   (Japan)

^ae GIFU UNIVERSITY   (Japan)

^af Cancer Institute of the Japanese Foundation for Cancer Research ^*  (Japan)

^ag KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^ah OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^ai Asama General Hospital   (Japan)

more..

Author keywords

Cohort study; Endometrial cancer mortality; Ever use of sex hormones; Hormone replacement therapy; Japan

Indexed keywords

SEX HORMONE;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; ENDOMETRIUM TUMOR; FEMALE; HEALTH SURVEY; HUMAN; JAPAN; LIFESTYLE; MIDDLE AGED; MORTALITY; RISK FACTOR; SOCIOECONOMICS;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GONADAL STEROID HORMONES; HEALTH SURVEYS; HUMANS; JAPAN; LIFE STYLE; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33748470791     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anderson D, Yoshizawa T, Gollschewski S, Atogami F, Courtney M (2004). Relationship between menopausal symptoms and menopausal status in Australian and Japanese women: preliminary analysis. Nurs Health Sci, 6, 173-80.
2. Beresford SAA, Weiss NS, Voigt LF, McKnight B (1997). Risk of endometrial cancer in relation to use of oestrogen combined wih cyclic progestagen therapy in postmenopausal women. Lancet, 349, 458-61.
3. Brinton L, Hoover R (1993). Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Obstet Gynecol, 81, 265-71.
4. Cushing KL, Weiss NS, Voigt LF, McKnight B, Beresford SAA (1998). Risk of endometrial cancer in relation to use of lowdose, unopposed estrogens. Obstet Gynecol, 91, 35-9.
5. Daly E, Gray A, Barlaw D, et al (1993). Measuring the impact of menopausal symptoms on quality of life. Br Med J, 307, 836-40.
6. Emons G, Huschmand-Nia A, Krauss T, Hinney B (2004). Hormone replacement therapy and endometrial cancer. Onkologie, 27, 207-10.
7. Goodman MT, Wilkens LR, Hankin JH, et al (1997). Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol, 146, 294-306.
8. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D (1995). Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol, 85, 304-13.
9. Graham JD, Clarke CL (1997). Physiological action of progesterone in target tissues. Endocrine Rev, 18, 502-19.
10. Health and Welfare Statistics Association. Kokumin eisei no do, 2002 (Trends in the nation's health, 2002). Tokyo: Kosei no shihyo, 2000 (In Japanese).
11. Hill DA, Weiss NS, Beresford SAA, et al (2000). Continuous combined hormone replacement therapy and risk of endometrial cancer. Am J Obstet Gynecol, 183, 1456-61.
12. Inoue M, Okayama A, Fujita M, et al (1994). A case-control study on risk factors for uterine endometrial cancer in Japan. Jpn J Cancer Res, 85, 346-50.
13. Jain MG, Howe GR, Rohan TE (2000). Nutritional factors and endometrial cancer in Ontario, Canada. Cancer Control, 7, 288-96.
14. Kitamura K (1999). The Pill in Japan: will approval ever come? Fam Plann Perspect, 31, 44-5
15. La Vecchia C, Decarli A, Fasoli M, Gentile A (1986). Nutrition and diet in the etiology of endometrial cancer. Cancer, 57, 1248-53.
16. Lacey JV Jr, Brinton LA, Lubin JH, et al (2005). Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev, 14, 1724-31.
17. Liu Y, Inoue M, Sobue T, Tsugane S for the JPHC Study Group (2005). Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population based cohort study. Int J Cancer, 117, 662-6.
18. McPherson K, Mant R (2005). Dose and duration of hormone use: understanding the effects of combined menopausal hormones on breast cancer better, 1976-2004. J Epidemiol Community Health, 59, 1078-9.
19. Mizunuma H, Honjo H, Aso T, et al (2001). Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women. Climacteric, 4, 293-8.
20. Muir C, Waterhouse J, Mack T, Powell J, Whelan S (Eds). Cancer incidence in five continents: Volume V. Lyon, France: IARC Sci. Pub. No. 88, 1987.
21. Nagata C, Matsushita Y, Shimizu H (1996). Prevalence of hormone replacement therapy and user's characteristics: a common survey in Japan. Maturitas, 25, 201-7.
22. Ohno Y, Tamakoshi A, and the JACC study group (2001). Japan Collaborative Cohort Study of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol, 11, 144-50.
23. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
24. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (Eds). Cancer Incidence in Five Continents: Volume VII. Lyon, France: IARC Sci. Pub. No. 143, 1997.
25. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (Eds). Cancer Incidence in Five Continents: Volume VIII. Eds. Lyon, France: IARC Sci. Pub. No. 155, 2002.
26. Parslov M, Lidegaard O, Klintorp S, et al (2000). Risk factors among young women with endometrial cancer: a Danish casecontrol study. Am J Obstet Gynecol, 182, 23-9.
27. Persson I, Adami H-O. Endometrial cancer. Adami H-O, Hunter D, Trichopoulos D eds. Textbook of Cancer Epidemiology. New York: Oxford University Press, 2002. pp.359-77.
28. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C (1999). Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control, 10, 253-60.
29. Pike MC, Peters RK, Cozen W, et al (1997). Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst, 89, 1110-16.
30. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990). Increased cell division as a cause of human cancer. Cancer Res, 50, 7415-21.
31. Pukkala E, Tulenheimo-Silfvast A, Leminen A (2001). Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997. Cancer Causes Control, 12, 111-5.
32. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, et al (1999). Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res, 59, 3658-62.
33. Shapiro JA, Weiss NS, Beresford SAA, Voigt LF (1998). Menopausal hormone use and endometrial cancer, by tumor grade and invasion. Epidemiology, 9, 99-101.
34. Shu XO, Zheng W, Potischman N, et al (1993). A population-based case-control study of dietary factors and endometrial cancer in Shanghai, Peoples Republic of China. Am J Epidemiol, 137, 155-65.
35. Voigt LF, Weiss NS, Chu J, et al (1991). Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet, 338, 274-7.
36. Weiderpass E, Adami H-O, Baron JA, et al (1999). Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst, 91, 1131-7.
37. Xu W-H, Xiang Y-B, Ruan Z-X, et al (2004). Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer, 108, 613-9.